Under Whitt’s bill, HB445, the Alabama Alcoholic Beverage Control Board would regulate the products and would issue licenses to manufacturers, wholesale distributors, and retailers. It would prohibit ...
Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback